<DOC>
	<DOCNO>NCT00167921</DOCNO>
	<brief_summary>The purpose study characterize systemic exposure bioavailability steady state Premarin速 Vaginal Cream compare Premarin速 oral tablet postmenopausal woman atrophic vaginitis .</brief_summary>
	<brief_title>Study Comparing Premarin速 Vaginal Cream Versus Premarin速 Oral Tablets Atrophic Vaginitis</brief_title>
	<detailed_description />
	<mesh_term>Vaginitis</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Atrophic Vaginitis</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<criteria>Generally healthy postmenopausal woman . Intact uterus . Clinical diagnosis moderate severe atrophic vaginitis .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>